GenScan AI Company Profile
Basic Company Overview
GenScan AI is an artificial intelligence company developing generative AI technology for medical imaging. The company’s flagship product, GenMRI, is designed to make MRI scans significantly faster while producing high-quality diagnostic images on existing MRI scanners.
GenScan AI says GenMRI can reduce MRI scan times by up to 90%, cutting a conventional 20-minute scan to as little as two minutes. The company aims to help healthcare providers increase scanning capacity, reduce diagnostic backlogs and enable patients to receive diagnoses sooner without the need for major investment in new MRI hardware.
Industry: Artificial Intelligence, Healthcare, Medical Imaging, MedTech
Technology: Generative AI, Medical Imaging, MRI
Product: GenMRI
Founder & CEO: Mary-Brenda Akoda
GenMRI
GenMRI is GenScan AI’s generative AI-powered medical imaging software. The company describes it as a real-time Generative AI imaging system that integrates with MRI scanners as cloud software.
The technology works by using fewer data points during the MRI scan and then applying AI to transform the accelerated input into high-quality diagnostic images.
According to GenScan AI, GenMRI can reduce a 20-minute MRI scan to approximately two minutes, representing a potential 90% reduction in scan time. The company says the technology is designed to work with existing scanners, eliminating the need for healthcare providers to purchase new MRI machines or make major hardware upgrades.
Key Features
- Up to 90% reduction in MRI scan time, according to GenScan AI.
- Can reduce a stated 20-minute scan to as little as two minutes.
- Generative AI-powered image reconstruction and enhancement.
- Cloud-based software designed to integrate with existing MRI scanners.
- Designed to increase MRI scanning capacity without new scanner hardware.
- Aims to reduce patient waiting times and diagnostic backlogs.
- Designed to improve the experience for patients and healthcare staff.
- Intended to reduce repeat scans and sedation requirements in relevant cases.
- Designed to support faster access to medical diagnosis.
How GenMRI Works
GenScan AI says GenMRI accelerates MRI scanning by collecting fewer data points during the scan and using its generative AI technology to transform the accelerated input into diagnostic-quality images.
The company presents the technology as an AI layer that works with existing MRI infrastructure rather than requiring healthcare providers to replace their scanners.
GenScan AI reports that a preliminary blinded review by consultant radiologists rated GenMRI scans as equivalent to conventional scans across all cases assessed. The company states that the results were based on a sample from more than 8,800 validated MRI scans and that the technology was at the pre-certification stage.
Healthcare Impact
GenScan AI is focused on addressing the capacity constraints associated with MRI services. The company says MRI scans can take between 20 minutes and 1.5 hours, contributing to significant waiting times and backlogs.
By shortening scan times, GenScan AI aims to enable healthcare providers to conduct more scans using their existing equipment. The company says this could increase capacity from approximately 20 patients per scanner per day to up to 200 patients per day, without additional scanner hardware investment.
The company also says faster scanning could help reduce sedation costs, extend scanner utilisation and lower the environmental impact associated with medical imaging.
Mission
GenScan AI’s mission is to make faster, higher-quality diagnostic imaging more accessible, reliable and sustainable for healthcare systems worldwide.
The company describes its approach as advancing medical imaging through next-generation, responsible AI while improving access to healthcare and streamlining healthcare delivery at scale.
Founder & CEO
Mary-Brenda Akoda
Mary-Brenda Akoda is the Founder and CEO of GenScan AI and is described by the company as an AI inventor.
According to GenScan AI, Akoda is a Google DeepMind Scholar and holds an MRes in Artificial Intelligence and Machine Learning from Imperial College London with Distinction. She previously worked as an AI research scientist and software engineer at Microsoft and has participated in the NHS Clinical Entrepreneur Programme.
The company also states that she led national AI research for ophthalmology, which it says was validated and patented, and that she is a former startup founder.
Team & Advisers
GenScan AI’s listed team includes:
Madza Eugette — Operations Coordinator
A Mastercard Foundation Scholar and healthcare professional supporting operations, partnerships, communications and stakeholder coordination at GenScan AI.
Dr Christos Kapatos — MedTech Adviser
A MedTech founder and operator with more than 22 years of experience, advising GenScan on company-building, commercialisation and execution.
Dr Ryan Kerstein — Clinical Adoption Adviser
A Consultant Surgeon and UK NHS innovation leader advising GenScan on clinical adoption, health-system needs and implementation pathways.
Richard Hall — RA/QA Adviser
Director of QMS Consultancy with more than 32 years of experience in MedTech regulatory affairs and quality assurance.
Recognition & Awards
GenScan AI has received recognition through a number of innovation and entrepreneurship programmes.
The company reports winning the Entrepreneurs’ Award in Social Innovation 2026, receiving a £10,000 prize and ongoing business support.
GenScan AI was also awarded a €10,000 Founderland Forward Grant, described by the company as equity-free funding.
The company’s founder, Mary-Brenda Akoda, has also been recognised through the NHS Clinical Entrepreneur Programme and selected as a Prometheus X Venture Fellow.
Contact Information
Company: GenScan AI
Email: info@genscan.ai
Website: www.genscan.ai
